Michael W. Bonney - Aug 2, 2023 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: Stephen Hall, Attorney-in-Fact For: Michael W. Bonney
Stock symbol
ALNY
Transactions as of
Aug 2, 2023
Transactions value $
-$1,195,310
Form type
4
Date filed
8/4/2023, 04:02 PM
Previous filing
May 19, 2023
Next filing
Dec 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Options Exercise $0 +22.5K $0.00 22.5K Aug 2, 2023 Direct
transaction ALNY Common Stock Sale -$54.3K -300 -1.33% $181.08 22.2K Aug 3, 2023 Direct F1, F2
transaction ALNY Common Stock Sale -$91.2K -500 -2.25% $182.45 21.7K Aug 3, 2023 Direct F1, F3
transaction ALNY Common Stock Sale -$103K -560 -2.58% $183.75 21.1K Aug 3, 2023 Direct F1, F4
transaction ALNY Common Stock Sale -$284K -1.54K -7.27% $184.89 19.6K Aug 3, 2023 Direct F1, F5
transaction ALNY Common Stock Sale -$319K -1.71K -8.75% $185.99 17.9K Aug 3, 2023 Direct F1, F6
transaction ALNY Common Stock Sale -$260K -1.39K -7.77% $187.04 16.5K Aug 3, 2023 Direct F1, F7
transaction ALNY Common Stock Sale -$84.5K -450 -2.73% $187.71 16K Aug 3, 2023 Direct F1, F8
holding ALNY Common Stock 4K Aug 2, 2023 by Trust F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Restricted Stock Units Options Exercise $0 -22.5K -100% $0.00* 0 Aug 2, 2023 Common Stock 22.5K Direct F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.
F2 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $181.00 to $181.25. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $182.13 to $183.06. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $183.20 to $184.15. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $184.48 to $185.44. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $185.49 to $186.31. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $186.53 to $187.53. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F8 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $187.58 to $187.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F9 The shares of ALNY common stock were purchased by the Michael W. Bonney Revocable Trust, of which the reporting person is trustee.
F10 Each restricted stock unit represents a contingent right to receive one share of ALNY common stock.
F11 The restricted stock units vest in full on the second anniversary of the grant date, August 2, 2021, provided the Reporting Person continues to serve as a director through such anniversary date, or earlier than such anniversary date if he ceases to serve as a director other than for cause or by his voluntary resignation as Executive Chair without the consent of the Board of Directors.